Borregaard ASA/Nkr BRG
1D1W1MYTD1Y5YMAX
Capital at risk
About Borregaard ASA
Borregaard ASA operates in the biochemical industry, focusing on the production of advanced and sustainable biochemicals derived from natural raw materials. The company offers a prominent range of products, including lignin-based chemicals, bioethanol, and cellulose, which are utilized across various industries such as agriculture, construction, and pharmaceuticals. Established in 1889, Borregaard has its headquarters in Sarpsborg, Norway, where it operates one of the world's most advanced biorefineries. The company's strategic advantage lies in its commitment to sustainability and innovation, leveraging its proprietary technology to produce environmentally friendly alternatives to petrochemical products.
- Ticker
- Nkr BRG
- Sector
- Materials
- Primary listing
- XOSL
- Employees
- 1,193
- Headquarters
- Sarpsborg, Norway
- Website
- www.borregaard.com
Borregaard ASA Metrics
BasicAdvanced
kr 15B
88.79
kr 1.69
0.57
kr 4.75
3.16%
Price and volume
Market cap
kr 15B
Beta
0.57
52-week high
kr 200.50
52-week low
kr 137.60
Average daily volume
76K
Dividend rate
kr 4.75
Financial strength
Current ratio
1.748
Quick ratio
0.987
Long term debt to equity
0.293
Total debt to equity
0.404
Dividend payout ratio (TTM)
281.07%
Interest coverage (TTM)
7.80%
Profitability
EBITDA (TTM)
1,618
Gross margin (TTM)
64.04%
Net profit margin (TTM)
2.18%
Operating margin (TTM)
14.90%
Effective tax rate (TTM)
61.39%
Revenue per employee (TTM)
kr 6,500,000
Management effectiveness
Return on assets (TTM)
7.42%
Return on equity (TTM)
2.76%
Valuation
Price to earnings (TTM)
88.793
Price to revenue (TTM)
1.936
Price to book
2.67
Price to tangible book (TTM)
2.71
Price to free cash flow (TTM)
16.581
Free cash flow yield (TTM)
6.03%
Free cash flow per share (TTM)
9.058
Dividend yield (TTM)
3.16%
Forward dividend yield
3.16%
Growth
Revenue change (TTM)
-0.30%
Earnings per share change (TTM)
-80.95%
3-year revenue growth (CAGR)
1.86%
10-year revenue growth (CAGR)
5.87%
3-year earnings per share growth (CAGR)
-43.48%
10-year earnings per share growth (CAGR)
-10.18%
3-year dividend per share growth (CAGR)
13.48%
10-year dividend per share growth (CAGR)
12.22%
Bulls say / Bears say
Second-quarter revenue increased to NOK 2.114 billion and EBITDA reached NOK 515 million despite a challenging environment; Fine Chemicals EBITDA rose to NOK 58 million from NOK 41 million on higher deliveries and a better mix. (Borregaard Q2 2026 results)
Cash generation strengthened substantially, with first-half operating cash flow rising to NOK 772 million from NOK 514 million, while leverage remained moderate at 1.20x and the equity ratio improved to 59%. (Borregaard Q2 2026 report)
Management is targeting NOK 150 million of annual cost savings, expects second-half wood costs to be 3–4% below the first half, and is emphasizing further specialisation and profitable growth at its September 2026 Capital Markets Day. (Borregaard Q2 2026 report; Borregaard Capital Markets Day 2026)
BioSolutions weakened materially: first-half EBITDA fell to NOK 566 million from NOK 687 million as energy costs, product mix and currency effects offset higher volumes. (Borregaard Q2 2026 report)
Speciality-cellulose pricing remains under pressure, with first-half average sales prices down 4% year over year and Q2 prices down 4%, while the company faces a preliminary 6.54% U.S. anti-dumping duty ahead of a final decision expected in October 2026. (Borregaard Q2 2026 report)
Borregaard recorded a NOK 337 million impairment on its Alginor investment and convertible loans, while Sarpsborg ground-stabilisation measures added NOK 30 million of costs; reported first-half profit before tax consequently fell to NOK 185 million from NOK 645 million. (Borregaard Q2 2026 report)
Data summarised monthly by Lightyear AI. Last updated on 11 Sept 2026.
Upcoming events
No upcoming events
Funds containing Borregaard ASA
AllGBPUSDEUR
Fund name | Fund size | Nkr BRG weighting |
|---|---|---|
Vanguard ESG Global All Cap£V3AB | £905M | 0.00% |
Vanguard FTSE Global All-cap$VALU | $199M | 0.00% |
Vanguard FTSE Global All-cap€VGLA | €171M | 0.00% |
Vanguard ESG Global All Cap€V3AA | €1.1B | 0.00% |
Vanguard FTSE Global All-cap£VALL | £147M | 0.00% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.